Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Endocyte Inc (ECYT)

Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Endocyte Inc 3000 KENT AVENUE SUITE A1-100 WEST LAFAYETTE IN 47906 USA

www.endocyte.com P: 765-463-7175

Description:

Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based in West Lafayette, Indiana.

Key Statistics

Overview:

Market Capitalization, $K 1,969,339
Shares Outstanding, K 82,090
Annual Sales, $ 70 K
Annual Net Income, $ -55,060 K
Last Quarter Sales, $ 90 K
Last Quarter Net Income, $ -12,610 K
60-Month Beta -0.01
% of Insider Shareholders 10.65%
% of Institutional Shareholders 75.62%

Growth:

1-Year Return 457.91%
3-Year Return 473.92%
5-Year Return 129.79%
5-Year Revenue Growth -99.80%
5-Year Earnings Growth -122.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 02/26/18
Latest Earnings Date 11/05/18
Earnings Per Share ttm -0.68
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 43.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ECYT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.19%
Return-on-Assets % -20.55%
Profit Margin % -78,657.14%
Debt/Equity 0.00
Price/Sales 28,144.80
Price/Cash Flow N/A
Price/Book 5.67
Book Value/Share 4.23
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar